Frontlight ResearchEarly access
Myeloproliferative neoplasms trials in United States
118 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
- Where
- Basking Ridge, Boston, Cleveland, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 37
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06773195 - Phase 1Taking peopleRopeginterferon for High Risk JAK2 Clonal Hematopoiesis
- Where
- Boston
- Age
- 18 years and over
- People
- 12
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT07249840 - Phase 2Taking peopleReduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
- Where
- Seattle
- Age
- 18 years to 70 years
- People
- 20
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT04370301 - Phase 1Taking peopleA Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
- Where
- Duarte, Sacramento, San Diego
- Age
- 18 years and over
- People
- 28
- Run by
- Aspera Biomedicines, Inc.
See details and how to joinNCT07250646 - No phaseTaking peopleEvaluation of the Pathobiology of CALR-mutated MPN Cells
- Where
- Charlotte, Winston-Salem
- Age
- 18 years and over
- People
- 35
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT06480591 - No phaseActive, not recruitingA ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
- Where
- Rochester
- Age
- 18 years to 100 years
- People
- 678 worldwide
- Run by
- FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
See details and how to joinNCT07203768 - Phase 2Taking peopleAllo HSCT Using RIC and PTCy for Hematological Diseases
- Where
- Minneapolis
- Age
- Up to 75 years
- People
- 56
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05805605 - No phaseTaking peopleCaris Chromoseq Data Collection
- Where
- Phoenix
- Age
- 18 years and over
- People
- 300
- Run by
- Caris Science, Inc.
See details and how to joinNCT07680868 - Phase 3CompletedA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Boston, Chicago, Cleveland, Detroit, Houston, Los Angeles, Nashville, New York, Oakland, Philadelphia, Stanford, Tampa
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060 - No phaseTaking peopleRegistry of Older Patients With Cancer
- Where
- Boone, Chapel Hill, Greenville, Hendersonville, Morehead City, New Bern, Raleigh
- Age
- 65 years and over
- People
- 3,000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137825 - Phase 2Taking peopleVedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
- Where
- Duarte
- Age
- 18 years to 80 years
- People
- 35
- Run by
- City of Hope Medical Center
See details and how to joinNCT06815003 - Phase 2Taking peopleMyeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
- Where
- Minneapolis
- Age
- Up to 60 years
- People
- 300
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03314974 - Phase 1Taking peopleOnvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
- Where
- Rochester
- Age
- 18 years and over
- People
- 25
- Run by
- Mayo Clinic
See details and how to joinNCT05549661 - Phase 1Taking peopleA Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
- Where
- Boston
- Age
- 12 years and over
- People
- 50
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04024761 - Phase 1Taking peoplePreemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
- Where
- Boston
- Age
- 18 years and over
- People
- 15
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06138587 - Early phase 1Taking peopleHyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
- Where
- Rochester
- Age
- 18 years to 75 years
- People
- 24
- Run by
- Omar Aljitawi
See details and how to joinNCT03964506 - Phase 1/2Taking peopleOpen Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
- Where
- Houston
- Age
- 18 years and over
- People
- 33
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06327100 - Phase 1Taking peoplePhase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
- Where
- Charlottesville
- Age
- 18 years and over
- People
- 23
- Run by
- University of Virginia
See details and how to joinNCT07270978 - Phase 2Taking peopleReparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
- Where
- Atlanta, Buffalo, Cleveland, Columbus, New York, Tampa, Winston-Salem
- Age
- 18 years and over
- People
- 10
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT05835466 - Early phase 1Taking peopleCombination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher Myelofibrosis, Who Have Had Prior Therapy With the Approved JAK Inhibitors or in Which Therapy With the Approved JAK Inhibitors is Not Appropriate, Contraindicated or Declined
- Where
- Fairway
- Age
- 18 years and over
- People
- 20
- Run by
- University of Kansas Medical Center
See details and how to joinNCT06414681 - Phase 1Taking peopleStudy of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- Where
- Boston, Chapel Hill, Chicago, Cincinnati, Columbus, Houston, Salt Lake City
- Age
- 13 years and over
- People
- 100
- Run by
- Newave Pharmaceutical Inc
See details and how to joinNCT04771572 - Phase 1Taking peopleA Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
- Where
- Baltimore, Boston, Cleveland, Duarte, Houston, Miami, Nashville, New York, Palo Alto, St Louis, Westwood, Winston-Salem
- Age
- 18 years and over
- People
- 290
- Run by
- Incyte Corporation
See details and how to joinNCT06034002 - Phase 1Taking peopleUAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
- Where
- Birmingham
- Age
- 4 weeks to 75 years
- People
- 50
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06047886 - Phase 1Taking peopleMomelotinib During and After HCT in Myelofibrosis
- Where
- Boston
- Age
- 18 years and over
- People
- 28
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07104799 - Phase 2Taking peopleCurcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 30
- Run by
- University of Southern California
See details and how to joinNCT06063486